BeOne Medicines Ltd. files DEF 14A

BeOne Medicines Ltd. is holding its 2026 Annual General Meeting on June 11, 2026, to vote on 20 proposals, including the election of 10 directors, ratification of auditors, and advisory votes on executive and director compensation. Shareholders are also asked to approve an increase in the share reserve for the company's equity incentive plans and grant mandates for share issuance and repurchase.